You're contacting media contact of this press release

Title: Cygenex Launches CyPHR AI-Powered Precision Health Assistant That Transforms DNA Into Real-Time Clinical Intelligence

United States, 25th Mar 2026 —Cygenex, a leader in precision medicine and pharmacogenomic risk optimization, today announced the launch of CyPHR (Cygenex Precision Health Response), an AI-powered health assistant designed to translate an individual’s genetic blueprint into actionable, real-time clinical guidance.CyPHR represents a major advancement in the application of pharmacogenomics, bridging the gap between genetic insight and everyday healthcare decisions. By integrating DNA data with real-time health inputs, CyPHR delivers a 360-degree view of an individual’s health, empowering both patients and providers to move from reactive care to proactive, precision-driven intervention.Eliminating Trial-and-Error MedicineTraditional prescribing models rely heavily on trial and error, often resulting in ineffective therapies, adverse drug reactions, and avoidable healthcare costs.CyPHR replaces this outdated approach with DNA-driven precision, analyzing how an individual’s genetic profile influences medication metabolism and response. By cross-referencing genetic data with current medications, CyPHR identifies potential risks, flags adverse interactions, and helps optimize medication selection and dosing.“For decades, healthcare has operated without visibility into one of the most critical variables of individual biology,” said Charles Clark, CEO. “CyPHR changes that. It transforms static genetic data into a dynamic, real-time decision engine that improves outcomes while reducing unnecessary risk.”A 24/7 Digital Health Co-PilotCyPHR functions as a continuous, AI-powered health companion providing users with ongoing guidance beyond the clinical setting. According to the product overview, CyPHR’s Precision Health Response assists with the following:Synthesizes genetic, lifesty...

This press release is issued by King Newswire